| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 80.21B | 79.17B | 76.87B | 75.45B | 66.14B | 59.56B |
| Gross Profit | 17.71B | 17.52B | 17.04B | 16.25B | 14.73B | 13.61B |
| EBITDA | 6.12B | 6.13B | 6.19B | 5.87B | 5.00B | 4.50B |
| Net Income | 3.25B | 3.27B | 3.27B | 2.42B | 2.29B | 1.56B |
Balance Sheet | ||||||
| Total Assets | 64.43B | 65.25B | 60.98B | 58.16B | 56.01B | 49.43B |
| Cash, Cash Equivalents and Short-Term Investments | 13.65B | 15.48B | 11.84B | 10.73B | 10.16B | 11.32B |
| Total Debt | 4.95B | 6.06B | 4.76B | 4.51B | 5.31B | 3.87B |
| Total Liabilities | 26.06B | 26.89B | 25.05B | 24.87B | 23.94B | 20.40B |
| Stockholders Equity | 36.34B | 36.33B | 33.90B | 31.29B | 30.09B | 29.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.25B | 2.04B | 2.58B | -339.00M | 3.12B |
| Operating Cash Flow | 0.00 | 5.84B | 4.21B | 3.96B | 1.23B | 4.20B |
| Investing Cash Flow | 0.00 | -1.69B | -2.05B | -1.39B | -2.37B | -2.26B |
| Financing Cash Flow | 0.00 | -531.00M | -1.08B | -2.02B | -22.00M | 1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥63.32B | 13.24 | ― | 3.95% | -0.98% | -15.59% | |
74 Outperform | ¥23.18B | 46.66 | ― | 2.77% | -7.31% | -44.40% | |
72 Outperform | ¥40.21B | 12.91 | ― | 3.95% | 0.32% | 75.60% | |
67 Neutral | ¥37.13B | 9.59 | ― | 3.14% | 3.61% | 1.46% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥12.23B | 10.99 | ― | 6.70% | 6.43% | 19.38% | |
59 Neutral | ¥30.26B | 4.17 | ― | 2.13% | 1.00% | 24.79% |